Food and Drug Administration Drug Safety Podcast
Due to risk of serious liver injury, FDA restricts use of obeticholic acid (Ocaliva) in primary biliary cholangitis (PBC) patients with advanced cirrhosis
- Author: Podcast
- Narrator: Podcast
- Publisher: Podcast
- Duration: 0:03:00
- More information
Informações:
Synopsis
Listen to FDA Drug Safety Podcast on due to risk of serious liver injury, FDA restricts use of Ocaliva in primary biliary cholangitis (PBC) patients with advanced cirrhosis
